Syndax Pharmaceuticals (SNDX) Other Working Capital Changes (2015 - 2026)

Syndax Pharmaceuticals' Other Working Capital Changes history runs 12 years deep, the most recent figure standing at -$7.8 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 30.79% year-over-year to -$7.8 million; the TTM figure through Mar 2026 stood at -$1.8 million (down 307.28% YoY), while the FY2024 annual figure was $8.4 million, up 1341.57% from the prior year.
• Other Working Capital Changes was -$7.8 million for Q1 2026 at Syndax Pharmaceuticals, down from -$4.8 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $10.8 million in Q2 2025 to a low of -$7.8 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged -$7500.0 across 5 years, with a median of -$1.3 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes jumped 2324.54% in 2022, then slumped 369.53% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at -$7.7 million in 2022, then surged by 91.19% to -$676000.0 in 2023, then sank by 369.53% to -$3.2 million in 2024, then slumped by 50.54% to -$4.8 million in 2025, then tumbled by 64.02% to -$7.8 million in 2026.
• The last three Other Working Capital Changes figures came in at -$7.8 million (Q1 2026), -$4.8 million (Q3 2025), and $10.8 million (Q2 2025), per Business Quant data.